Dichloroacetate modulates the oxidative stress and inflammatory response to exercise in COPD

Chest

Volumn 136, Issue 3, 2009, Pages 744-751

  Mercken, Evi M ^a   Calvert, Lori D ^b   Singh, Sally J ^b   Hageman, Geja J ^a   Schols, Annemie M ^a   Steiner, Michael C ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLOROACETIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; INTERLEUKIN 6; MALONALDEHYDE; PYRUVATE DEHYDROGENASE COMPLEX; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG INFUSION; ENZYME ACTIVITY; EXERCISE; FEMALE; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; URIC ACID URINE LEVEL; URINALYSIS; VENOUS BLOOD; WORKLOAD;

EID: 70049108728     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2890     Document Type: Article

References (42)

1. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159: S1-S40
2. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:367-370 (Pubitemid 41699698)
3. Berton E, Antonucci R, Palange P. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 2001; 56:418-422 (Pubitemid 34134121)
4. Heunks LM, Vina J, van Herwaarden CL, et al. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999; 277:R1697-R1704 (Pubitemid 30043777)
5. Mercken EM, Hageman GJ, Schols AM, et al. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:994-1001 (Pubitemid 41476536)
6. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:442-447 (Pubitemid 26269117)
7. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 2002; 19:617-625 (Pubitemid 34285157)
8. Maltais F, LeBlanc P, Whittom F, et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000; 55:848-853 (Pubitemid 30744219)
9. Steiner MC, Evans R, Deacon SJ, et al. Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax 2005; 60:932-936 (Pubitemid 41598208)
10. McCord JM, Roy RS, Schaffer SW. Free radicals and myocardial ischemia: the role of xanthine oxidase. Adv Myocardiol 1985; 5:183-189
11. Sjodin B, Hellsten Westing Y, et al. Biochemical mechanisms for oxygen free radical formation during exercise. Sports Med 1990; 10:236-254 (Pubitemid 20304380)
12. Randle PJ, Garland PB, Hales CN, et al. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1:785-789
13. Stacpoole PW, Nagaraja NV, Hutson AD. Efficacy of dichloroacetate as a lactate-lowering drug. J Clin Pharmacol 2003; 43:683-691
14. Stacpoole PW, Harman EM, Curry SH, et al. Treatment of lactic acidosis with dichloroacetate. N Engl J Med 1983; 309:390-396
15. Calvert LD, Shelley R, Singh SJ, et al. Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in COPD. Am J Respir Crit Care Med 2008; 177:1090-1094
16. Petersen AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 2006; 57(suppl):43-51 (Pubitemid 46548766)
17. Starkie R, Ostrowski SR, Jauffred S, et al. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans. FASEB J 2003; 17:884-886
18. Pedersen BK, Akerstrom TC, Nielsen AR, et al. Role of myokines in exercise and metabolism. J Appl Physiol 2007; 103:1093-1098
19. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555 (Pubitemid 47403272)
20. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: report working party standardization of lung function tests, European Community for Steel and Coal; official statement of the European Respiratory Society. Eur Respir J 1993; 16(suppl):5-40
21. Steiner MC, Barton RL, Singh SJ, et al. Bedside methods versus dual energy x-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002; 19:626-631 (Pubitemid 34285158)
22. Lepage G, Munoz G, Champagne J, et al. Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. Anal Biochem 1991; 197:277-283
23. Lux O, Naidoo D, Salonikas C. Improved HPLC method for the simultaneous measurement of allantoin and uric acid in plasma. Ann Clin Biochem 1992; 29:674-675
24. Falco GL, Lloret SM, Gomez FB, et al. Creatinine determination in urine samples by batchwise kinetic procedure and flow injection analysis using the Jaffe reaction: chemometric study. Talanta 2001; 55:1079-1089
25. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34:497-500 (Pubitemid 18102175)
26. Van Kampen EJ, Zijlstra WG. Determination of hemoglobin and its derivatives. Adv Clin Chem 1965; 8:141-187
27. Tschakovsky ME, Hughson RL. Interaction of factors determining oxygen uptake at the onset of exercise. J Appl Physiol 1999; 86:1101-1113
28. Vandeputte C, Guizon I, Genestie-Denis I, et al. A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: performance study of a new miniaturized protocol. Cell Biol Toxicol 1994; 10:415-421 (Pubitemid 24377319)
29. Calvert LD, Singh SJ, Greenhaff PL, et al. The plasma ammonia response to cycle exercise in COPD. Eur Respir J 2008; 31:751-758
30. Roberts PA, Loxham SJ, Poucher SM, et al. The acetyl group deficit at the onset of contraction in ischaemic canine skeletal muscle. J Physiol 2002; 544:591-602
31. Timmons JA, Poucher SM, Constantin-Teodosiu D, et al. Metabolic responses from rest to steady state determine contractile function in ischemic skeletal muscle. Am J Physiol 1997; 273:E233-238 (Pubitemid 27427806)
32. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 2002; 16:1335-1347
33. Matthys P, Mitera T, Heremans H, et al. Anti-γ interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect Immun 1995; 63:1158-1164
34. Mizuhara H, O'Neill E, Seki N, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179:1529-1537 (Pubitemid 24129570)
35. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98:1154-1162
36. Ostrowski K, Schjerling P, Pedersen BK. Physical activity and plasma interleukin-6 in humans: effect of intensity of exercise. Eur J Appl Physiol 2000; 83:512-515 (Pubitemid 32014240)
37. Ostrowski K, Rohde T, Zacho M, et al. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 1998; 508:949-953 (Pubitemid 28220743)
38. Plomgaard P, Nielsen AR, Fischer CP, et al. Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 2007; 50:2562-2571 (Pubitemid 350060651)
39. Reid MB, Li YP. Cytokines and oxidative signalling in skeletal muscle. Acta Physiol Scand 2001; 171:225-232 (Pubitemid 32823790)
40. Greenhaff PL, Campbell-O'Sullivan SP, Constantin-Teodosiu D, et al. Metabolic inertia in contracting skeletal muscle: a novel approach for pharmacological intervention in peripheral vascular disease. Br J Clin Pharmacol 2004; 57:237-243 (Pubitemid 38296986)
41. Timmons JA, Gustafsson T, Sundberg CJ, et al. Muscle acetyl group availability is a major determinant of oxygen deficit in humans during submaximal exercise. Am J Physiol 1998; 274:E377-E380 (Pubitemid 28140824)
42. Heigenhauser GJ, Parolin ML. Role of pyruvate dehydrogenase in lactate production in exercising human skeletal muscle. Adv Exp Med Biol 1999; 474:205-218